|
CEP63 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.158900E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.287250E-01 |
| Normal-vs-Stage2 |
3.396400E-02 |
| Normal-vs-Stage3 |
1.409340E-04 |
| Normal-vs-Stage4 |
8.677400E-03 |
| Stage1-vs-Stage2 |
1.650760E-01 |
| Stage1-vs-Stage3 |
5.661000E-03 |
| Stage1-vs-Stage4 |
9.638500E-02 |
| Stage2-vs-Stage3 |
5.759800E-01 |
| Stage2-vs-Stage4 |
9.917200E-01 |
| Stage3-vs-Stage4 |
5.240400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.704600E-03 |
| Normal-vs-AfricanAmerican |
3.173900E-02 |
| Normal-vs-Asian |
8.723800E-01 |
| Caucasian-vs-AfricanAmerican |
6.287000E-01 |
| Caucasian-vs-Asian |
3.697400E-01 |
| AfricanAmerican-vs-Asian |
3.121000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.808570E-04 |
| Normal-vs-Female |
3.482400E-01 |
| Male-vs-Female |
2.759200E-03 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.857800E-01 |
| Normal-vs-Age(41-60Yrs) |
3.946000E-02 |
| Normal-vs-Age(61-80Yrs) |
1.497780E-03 |
| Normal-vs-Age(81-100Yrs) |
1.88963999999681E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.088590E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.634400E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.603140E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.076400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.562100E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.800000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.732640E-01 |
| Normal-vs-Grade 2 |
9.592000E-02 |
| Normal-vs-Grade 3 |
2.817100E-04 |
| Normal-vs-Grade 4 |
1.679860E-02 |
| Grade 1-vs-Grade 2 |
9.369500E-02 |
| Grade 1-vs-Grade 3 |
9.896300E-03 |
| Grade 1-vs-Grade 4 |
3.533800E-02 |
| Grade 2-vs-Grade 3 |
2.495900E-02 |
| Grade 2-vs-Grade 4 |
1.903420E-01 |
| Grade 3-vs-Grade 4 |
7.947200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.063410E-01 |
| Normal-vs-ccB subtype |
1.606120E-02 |
| ccA subtype-vs-ccB subtype |
3.347200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.317000E-03 |
| Normal-vs-N1 |
7.535800E-01 |
| N0-vs-N1 |
4.112800E-01 |
|
|
